Page last updated: 2024-08-25

rosiglitazone and Erythrophagocytic Lymphohistiocytosis, Familial

rosiglitazone has been researched along with Erythrophagocytic Lymphohistiocytosis, Familial in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chang, Y; Chen, YL; Chuang, HC; Hsieh, WC; Lan, BS; Su, IJ	1

Other Studies

1 other study(ies) available for rosiglitazone and Erythrophagocytic Lymphohistiocytosis, Familial

Article	Year
Efficacy of peroxisome proliferator activated receptor agonist in the treatment of virus-associated haemophagocytic syndrome in a rabbit model. Antiviral therapy, 2010, Volume: 15, Issue:1 Topics: Administration, Oral; Animals; Callithrix; Cell Line; Dose-Response Relationship, Drug; Herpesviridae Infections; Herpesvirus 4, Human; Humans; Hypoglycemic Agents; Lymphohistiocytosis, Hemophagocytic; PPAR gamma; Rabbits; Rosiglitazone; Simplexvirus; Thiazolidinediones; Treatment Outcome; Tumor Necrosis Factor-alpha; Viral Load; Virus Replication	2010

Article

Year

Efficacy of peroxisome proliferator activated receptor agonist in the treatment of virus-associated haemophagocytic syndrome in a rabbit model.

Antiviral therapy, 2010, Volume: 15, Issue:1

Topics: Administration, Oral; Animals; Callithrix; Cell Line; Dose-Response Relationship, Drug; Herpesviridae Infections; Herpesvirus 4, Human; Humans; Hypoglycemic Agents; Lymphohistiocytosis, Hemophagocytic; PPAR gamma; Rabbits; Rosiglitazone; Simplexvirus; Thiazolidinediones; Treatment Outcome; Tumor Necrosis Factor-alpha; Viral Load; Virus Replication

2010